Dx & Vx Co., Ltd.
Research Dx & Vx Co., Ltd. (180400.KQ) on Bullrun: market cap KRW 215.56B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker180400.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 215.56B
- Financial periodQ2 2026
- RevenueKRW 6.40B
- Net income-KRW 5.57B
- Free cash flow-KRW 5.77B
- Gross margin12.1%
Valuation Snapshot
latest market cap is KRW 215.56B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 215.56B | n/a | n/a | n/a |
Dividend history
About Dx & Vx Co., Ltd.
Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services; medical data; and funeral home operation services. It provides bacterial vaccine for respiratory disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dx & Vx Co., Ltd.'s market cap?
Dx & Vx Co., Ltd.'s market capitalization is KRW 215.56B.
What does Dx & Vx Co., Ltd. do?
Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services; medical data; and funeral home operation services.